{"id":27659,"date":"2025-04-29T16:59:00","date_gmt":"2025-04-29T23:59:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/uncategorized\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients-2\/"},"modified":"2026-04-30T14:54:53","modified_gmt":"2026-04-30T21:54:53","slug":"idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/","title":{"rendered":"Idelvion: Un f\u00e1rmaco con protecci\u00f3n antihemorr\u00e1gica duradera y comprobada para pacientes con hemofilia B"},"content":{"rendered":"<p>Idelvion es un medicamento inyectable que generalmente se receta a ni\u00f1os y adultos con <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/hemophilia-a-vs-b-whats-the-difference\/\">Hemofilia B<\/a> (tambi\u00e9n llamada deficiencia cong\u00e9nita del factor IX o enfermedad de Christmas).<\/p>\n\n\n\n<p>Contiene una versi\u00f3n recombinante del factor de coagulaci\u00f3n IX, que ayuda a controlar y prevenir episodios de sangrado en pacientes con hemofilia B.<\/p>\n\n\n\n<div  id=\"call-to-action-0720943088ff1d4e670c7b83551a9be3\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:(877) 778-0318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Tambi\u00e9n conocido por su nombre gen\u00e9rico, \u201cFactor de coagulaci\u00f3n IX (recombinante), prote\u00edna de fusi\u00f3n de alb\u00famina\u201d, este medicamento fue aprobado por la <a href=\"https:\/\/www.fda.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos<\/a> en 2016. S\u00f3lo se puede obtener mediante receta m\u00e9dica.<\/p>\n\n\n\n<p>Si su m\u00e9dico le ha recetado a usted o a alguien que le importa infusiones de Idelvion, debe saber c\u00f3mo funciona en el cuerpo, los efectos secundarios que puede causar y qu\u00e9 medidas de precauci\u00f3n deben tomarse.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Usage_or_Indication\" >Uso o indicaci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Composition_and_Mechanism_of_Action\" >Composici\u00f3n y mecanismo de acci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Dosage_Forms_and_Strengths\" >Formas de dosificaci\u00f3n y concentraciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Dosage_and_Administration\" >Dosis y administraci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#1_Dosage_for_Routine_Prophylaxis\" >1. Dosis para profilaxis de rutina<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#2_Dosage_for_On-Demand_Treatment\" >2. Dosis para el tratamiento a demanda<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#3_Dosage_to_Control_Bleeding_Surrounding_Surgery\" >3. Dosis para controlar el sangrado alrededor de la cirug\u00eda<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Common_Side_Effects_of_Idelvion\" >Efectos secundarios comunes del Idelvion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Contraindications_and_Warnings\" >Contraindicaciones y advertencias<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Precautionary_Measures_You_Should_Take\" >Medidas de precauci\u00f3n que debe tomar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#Estimated_Cost_of_Idelvion\" >Costo estimado de Idelvion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#How_AmeriPharma%C2%AE_Specialty_Pharmacy_Can_Support_Your_Hemophilia_B_Treatment\" >C\u00f3mo la farmacia especializada AmeriPharma\u00ae puede apoyar su tratamiento para la hemofilia B<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-usage-or-indication\"><span class=\"ez-toc-section\" id=\"Usage_or_Indication\"><\/span>Uso o indicaci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Idelvion normalmente se prescribe a pacientes con hemofilia B (ni\u00f1os y adultos) que carecen del factor de coagulaci\u00f3n IX o tienen un nivel inferior al normal.<\/p>\n\n\n\n<p>El factor IX de coagulaci\u00f3n ayuda a coagular la sangre, y si tiene hemofilia B, la sangre tarda m\u00e1s en coagularse, lo que provoca un episodio de sangrado. Los episodios de sangrado pueden ocurrir despu\u00e9s de una lesi\u00f3n o cirug\u00eda, o a veces sin una causa aparente.<\/p>\n\n\n\n<p>Las infusiones de Idelvion se utilizan para controlar estas situaciones, que incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tratamiento de los episodios de sangrado cuando ocurren<\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/how-to-stop-bleeding-in-hemophilia-patients\/\">Manejo del sangrado excesivo<\/a> antes, durante o despu\u00e9s de un procedimiento quir\u00fargico<\/li>\n\n\n\n<li>Para la profilaxis de rutina para prevenir o reducir la frecuencia de episodios de sangrado.<\/li>\n<\/ul>\n\n\n\n<p>Idelvion no debe utilizarse para inducir tolerancia inmunitaria en pacientes con hemofilia B. La inducci\u00f3n de tolerancia inmunitaria es un tratamiento que ayuda al sistema inmunitario a aceptar el factor de coagulaci\u00f3n, evitando que lo rechace.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-composition-and-mechanism-of-action\"><span class=\"ez-toc-section\" id=\"Composition_and_Mechanism_of_Action\"><\/span>Composici\u00f3n y mecanismo de acci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Idelvion se compone de un factor de coagulaci\u00f3n IX recombinante fusionado gen\u00e9ticamente y alb\u00famina recombinante. Esta fusi\u00f3n prolonga su permanencia en el organismo, lo que significa que permanece m\u00e1s tiempo y puede administrarse con menor frecuencia que otros productos de factor.<\/p>\n\n\n\n<p>En cuanto a su mecanismo de acci\u00f3n, el principio activo del f\u00e1rmaco, <a href=\"https:\/\/go.drugbank.com\/drugs\/DB13884\" target=\"_blank\" rel=\"noreferrer noopener\">albutrepenonacog alfa<\/a>, funciona de la misma manera que un factor de coagulaci\u00f3n humano y ayuda a que la sangre coagule de manera m\u00e1s eficiente.<\/p>\n\n\n\n<p>Reemplaza el factor IX faltante, controlando as\u00ed temporalmente el sangrado en personas con hemofilia B.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-forms-and-strengths\"><span class=\"ez-toc-section\" id=\"Dosage_Forms_and_Strengths\"><\/span>Formas de dosificaci\u00f3n y concentraciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Idelvion se presenta como polvo liofilizado en un vial monodosis reconstituido con el diluyente (agua est\u00e9ril) incluido. Actualmente, las infusiones de Idelvion est\u00e1n disponibles en cinco concentraciones diferentes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>250 unidades internacionales (UI)<\/li>\n\n\n\n<li>500 UI<\/li>\n\n\n\n<li>1.000 UI<\/li>\n\n\n\n<li>2.000 UI<\/li>\n\n\n\n<li>3.500 UI<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-9e9582ce73179d784d0ef3d74e16e0a8\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#form\">M\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-and-administration\"><span class=\"ez-toc-section\" id=\"Dosage_and_Administration\"><\/span>Dosis y administraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Su m\u00e9dico le prescribir\u00e1 una dosis seg\u00fan sus:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Edad<\/li>\n\n\n\n<li>Peso corporal (kg)<\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/\">Estado cl\u00ednico<\/a><\/li>\n\n\n\n<li>Gravedad de la deficiencia del factor IX<\/li>\n\n\n\n<li>Ubicaci\u00f3n y extensi\u00f3n del sangrado<\/li>\n<\/ul>\n\n\n\n<p>La dosis se mezcla con diluyente y se administra por v\u00eda intravenosa (una inyecci\u00f3n en una vena).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-dosage-for-routine-prophylaxis\"><span class=\"ez-toc-section\" id=\"1_Dosage_for_Routine_Prophylaxis\"><\/span>1. Dosis para profilaxis de rutina<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El rango de dosis recomendado de Idelvion para pacientes (\u226512 a\u00f1os de edad) es de 20 a 45 UI por kg de peso corporal, administrada cada 7 d\u00edas.<\/p>\n\n\n\n<p>Los pacientes que est\u00e1n bien controlados con un r\u00e9gimen de 7 d\u00edas pueden cambiarse a un intervalo de 14 d\u00edas con 50 a 75 UI por kg de peso corporal.<\/p>\n\n\n\n<p>Para los ni\u00f1os menores de 12 a\u00f1os se administra una dosis de 40 \u2013 55 UI por kg cada 7 d\u00edas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-dosage-for-on-demand-treatment\"><span class=\"ez-toc-section\" id=\"2_Dosage_for_On-Demand_Treatment\"><\/span>2. Dosis para el tratamiento a demanda<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Cuando se produce una hemorragia, una sola dosis de Idelvion suele ser suficiente para detenerla. La dosis exacta de las infusiones de Idelvion depende de la gravedad de la hemorragia y de su localizaci\u00f3n. Por ejemplo:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para <strong>sangrados leves a moderados<\/strong> (como en el <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/hemophilia-and-joint-health-how-to-prevent-and-treat-joint-damage\/\">articulaciones<\/a> o m\u00fasculos), el medicamento se administra cada 48 a 72 horas para alcanzar niveles de factor IX de 30 a 60 UI\/dl hasta que se detenga el sangrado.<\/li>\n\n\n\n<li>Para <strong>hemorragias graves<\/strong> (como en el cerebro o el est\u00f3mago), el medicamento se administra cada 48 a 72 horas durante la primera semana para alcanzar niveles de factor IX de 60 a 100 UI\/dl, seguido de 7 a 14 d\u00edas de tratamiento para sanar adecuadamente.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-dosage-to-control-bleeding-surrounding-surgery\"><span class=\"ez-toc-section\" id=\"3_Dosage_to_Control_Bleeding_Surrounding_Surgery\"><\/span>3. Dosis para controlar el sangrado alrededor de la cirug\u00eda<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Para controlar el sangrado durante o despu\u00e9s de una cirug\u00eda, se utiliza Idelvion para mantener los niveles de actividad del factor IX en el rango objetivo o por encima de \u00e9l. Por ejemplo:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para procedimientos quir\u00fargicos menores (por ejemplo, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/hemophilia-and-dental-treatment-how-to-prevent-and-treat-mouth-injuries\/\">Extracci\u00f3n dental<\/a>): Para mantener los niveles de actividad del factor IX entre 50 y 80 UI\/dl, se deben administrar infusiones de Idelvion cada 48 a 72 horas durante un m\u00ednimo de un d\u00eda hasta que se complete la curaci\u00f3n.<\/li>\n\n\n\n<li>Para procedimientos quir\u00fargicos mayores (por ejemplo, reemplazo de cadera o cirug\u00eda cerebral): para mantener los niveles de actividad del factor IX entre 60 y 100 UI\/dl, se debe administrar Idelvion cada 48 a 72 horas durante la primera semana, seguido de 7 a 14 d\u00edas adicionales hasta que se complete la recuperaci\u00f3n.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-common-side-effects-of-idelvion\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects_of_Idelvion\"><\/span>Efectos secundarios comunes del Idelvion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"273\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects.jpg\" alt=\"\" class=\"wp-image-27661\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-300x195.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-86x56.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-167x109.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-280x182.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/headache-Idelvion-side-effects-370x241.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Todos los medicamentos pueden tener efectos secundarios. Algunos son leves y temporales, mientras que otros pueden ser graves y requerir atenci\u00f3n m\u00e9dica inmediata. Los efectos secundarios m\u00e1s comunes notificados por m\u00e1s del 11% de las personas durante los ensayos de profilaxis incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Erupci\u00f3n<\/li>\n\n\n\n<li><a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/9998-eczema\" target=\"_blank\" rel=\"noreferrer noopener\">Eczema<\/a><\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Hipersensibilidad (reacci\u00f3n al\u00e9rgica)<\/li>\n<\/ul>\n\n\n\n<p>Siempre consulte a su m\u00e9dico o centro de tratamiento de hemofilia si experimenta alg\u00fan efecto secundario despu\u00e9s de tomar Idelvion.<\/p>\n\n\n\n<div  id=\"call-to-action-143190a94a7d22f0e0a586401c8a185e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:(877) 778-0318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-contraindications-and-warnings\"><span class=\"ez-toc-section\" id=\"Contraindications_and_Warnings\"><\/span>Contraindicaciones y advertencias<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los pacientes con antecedentes de reacciones anafil\u00e1cticas o de hipersensibilidad grave al Idelvion, al factor IX de coagulaci\u00f3n humano recombinante, a la prote\u00edna de fusi\u00f3n de alb\u00famina o a cualquiera de los ingredientes inactivos del vial no deben tomar este medicamento.<\/p>\n\n\n\n<p>Al utilizar productos que contienen factor IX, los pacientes pueden desarrollar tromboembolia (por ejemplo, embolia pulmonar, trombosis venosa y trombosis arterial).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-precautionary-measures-you-should-take\"><span class=\"ez-toc-section\" id=\"Precautionary_Measures_You_Should_Take\"><\/span>Medidas de precauci\u00f3n que debe tomar<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Siempre consulte a su proveedor de atenci\u00f3n m\u00e9dica antes de administrar infusiones de Idelvion si usted\/tiene:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Est\u00e1 embarazada o planea quedar embarazada (porque el medicamento puede da\u00f1ar al beb\u00e9 que est\u00e1 por nacer)<\/li>\n\n\n\n<li>Lactancia materna o plan para amamantar<\/li>\n\n\n\n<li>Tuvo una reacci\u00f3n al\u00e9rgica a alguno de los productos Factor IX antes de tomar Idelvion<\/li>\n\n\n\n<li>Tomar medicamentos de venta libre u otros factores de coagulaci\u00f3n como carfilzomib, efgartigimod alfa o rozanolixizumab, suplementos o productos a base de hierbas.<\/li>\n\n\n\n<li>\u00bfTuvo alg\u00fan problema m\u00e9dico?<\/li>\n\n\n\n<li>Inhibidores del factor IX de la coagulaci\u00f3n (porque el medicamento podr\u00eda no funcionar en su caso)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-estimated-cost-of-idelvion\"><span class=\"ez-toc-section\" id=\"Estimated_Cost_of_Idelvion\"><\/span>Costo estimado de Idelvion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El precio de un kit intravenoso de prote\u00edna de fusi\u00f3n de alb\u00famina recombinante Idelvion puede variar seg\u00fan su cobertura de seguro. El fabricante ofrece programas de asistencia para copagos. Cont\u00e1ctenos si desea consultarlo. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">asistencia financiera<\/a> o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/idelvion-copay-assistance\/\" type=\"link\" id=\"https:\/\/ameripharmaspecialty.com\/idelvion-copay-assistance\/\">Asistencia para el copago del programa Idelvion<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-ameripharma-specialty-pharmacy-can-support-your-hemophilia-b-treatment\"><span class=\"ez-toc-section\" id=\"How_AmeriPharma%C2%AE_Specialty_Pharmacy_Can_Support_Your_Hemophilia_B_Treatment\"><\/span>C\u00f3mo la farmacia especializada AmeriPharma\u00ae puede apoyar su tratamiento para la hemofilia B<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El manejo de la hemofilia B con infusiones de Idelvion puede ayudar a reducir los episodios de sangrado y mejorar la calidad de vida.<\/p>\n\n\n\n<p>Si padece hemofilia B o a su hijo le han diagnosticado esta enfermedad, puede confiar en <a href=\"https:\/\/ameripharmaspecialty.com\/es\/about-us\/\">Farmacia especializada AmeriPharma\u00ae<\/a> Para obtener soporte. Nuestro equipo acreditado por ACHC <a href=\"https:\/\/ameripharmaspecialty.com\/es\/\">farmacia especializada<\/a> Ofrece medicamentos dif\u00edciles de encontrar e infusiones en el hogar para pacientes con hemofilia.<\/p>\n\n\n\n<p>Brindamos servicio a m\u00e1s de 40 estados y territorios de EE. UU. con coordinaci\u00f3n de servicios completos, asistencia con copagos y soporte las 24 horas, los 7 d\u00edas de la semana, los 365 d\u00edas del a\u00f1o. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/book-a-call\/\">Reservar una llamada<\/a> con nosotros hoy para comenzar con el tratamiento Idelvion.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Idelvion es un medicamento inyectable que se suele recetar a ni\u00f1os y adultos con hemofilia B (tambi\u00e9n llamada deficiencia cong\u00e9nita del factor IX o enfermedad de Christmas). Contiene una versi\u00f3n recombinante del factor IX de la coagulaci\u00f3n, que ayuda a controlar y prevenir los episodios de sangrado en pacientes con hemofilia B.<\/p>","protected":false},"author":25,"featured_media":27658,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-27659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hemophilia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Idelvion: Long-Lasting Bleed Protection for Hemophilia B<\/title>\n<meta name=\"description\" content=\"Discover Idelvion, a drug with proven long-lasting bleed protection for Hemophilia B patients. Explore the cost, dosing, and side effects of Idelvion infusions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Idelvion: Long-Lasting Bleed Protection for Hemophilia B\" \/>\n<meta property=\"og:description\" content=\"Discover Idelvion, a drug with proven long-lasting bleed protection for Hemophilia B patients. Explore the cost, dosing, and side effects of Idelvion infusions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-29T23:59:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-30T21:54:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"Idelvion: A Drug With Proven Long-Lasting Bleed Protection for Hemophilia B Patients\",\"datePublished\":\"2025-04-29T23:59:00+00:00\",\"dateModified\":\"2026-04-30T21:54:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/\"},\"wordCount\":1051,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/young-patient-hemophilia-idelvion.jpg\",\"articleSection\":[\"Hemophilia\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/\",\"name\":\"Idelvion: Long-Lasting Bleed Protection for Hemophilia B\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/young-patient-hemophilia-idelvion.jpg\",\"datePublished\":\"2025-04-29T23:59:00+00:00\",\"dateModified\":\"2026-04-30T21:54:53+00:00\",\"description\":\"Discover Idelvion, a drug with proven long-lasting bleed protection for Hemophilia B patients. Explore the cost, dosing, and side effects of Idelvion infusions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/young-patient-hemophilia-idelvion.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/young-patient-hemophilia-idelvion.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A doctor stroking the head of a young patient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/hemophilia\\\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Idelvion: A Drug With Proven Long-Lasting Bleed Protection for Hemophilia B Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Idelvion: Protecci\u00f3n duradera contra hemorragias en pacientes con hemofilia B","description":"Descubra Idelvion, un f\u00e1rmaco con protecci\u00f3n antihemorr\u00e1gica duradera y comprobada para pacientes con hemofilia B. Explore el costo, la dosis y los efectos secundarios de las infusiones de Idelvion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/","og_locale":"es_MX","og_type":"article","og_title":"Idelvion: Long-Lasting Bleed Protection for Hemophilia B","og_description":"Discover Idelvion, a drug with proven long-lasting bleed protection for Hemophilia B patients. Explore the cost, dosing, and side effects of Idelvion infusions.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-04-29T23:59:00+00:00","article_modified_time":"2026-04-30T21:54:53+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"Idelvion: A Drug With Proven Long-Lasting Bleed Protection for Hemophilia B Patients","datePublished":"2025-04-29T23:59:00+00:00","dateModified":"2026-04-30T21:54:53+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/"},"wordCount":1051,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg","articleSection":["Hemophilia"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/","url":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/","name":"Idelvion: Protecci\u00f3n duradera contra hemorragias en pacientes con hemofilia B","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg","datePublished":"2025-04-29T23:59:00+00:00","dateModified":"2026-04-30T21:54:53+00:00","description":"Descubra Idelvion, un f\u00e1rmaco con protecci\u00f3n antihemorr\u00e1gica duradera y comprobada para pacientes con hemofilia B. Explore el costo, la dosis y los efectos secundarios de las infusiones de Idelvion.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg","width":1280,"height":853,"caption":"A doctor stroking the head of a young patient"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/hemophilia\/idelvion-a-drug-with-proven-long-lasting-bleed-protection-for-hemophilia-b-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Idelvion: A Drug With Proven Long-Lasting Bleed Protection for Hemophilia B Patients"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Dr. Mark Alfonso, PharmD, BCMTMS","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"El Dr. Mark Alfonso, doctor en farmacia, naci\u00f3 y creci\u00f3 en Pueblo, Colorado. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Colorado, en el Campus M\u00e9dico Anschutz, en 2010. Obtuvo su certificaci\u00f3n en gesti\u00f3n de terapias farmacol\u00f3gicas en 2022. Lo m\u00e1s gratificante de su trabajo es ayudar a responder las preguntas e inquietudes de los pacientes. Sus \u00e1reas de especializaci\u00f3n son la farmacia comunitaria y la gesti\u00f3n de terapias farmacol\u00f3gicas. En su tiempo libre, disfruta de la lectura y correr.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Idelvion is an injectable drug that is typically prescribed to children and adults with Hemophilia B (also called congenital Factor IX deficiency or Christmas disease). It contains a recombinant version of clotting factor IX, which helps to control and prevent bleeding episodes in Hemophilia B patients.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/07\/young-patient-hemophilia-idelvion.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/hemophilia\/\" rel=\"category tag\">Hemophilia<\/a>","rttpg_excerpt":"Idelvion is an injectable drug that is typically prescribed to children and adults with Hemophilia B (also called congenital Factor IX deficiency or Christmas disease). It contains a recombinant version of clotting factor IX, which helps to control and prevent bleeding episodes in Hemophilia B patients.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27659"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27658"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27659"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}